SWOT Analysis of Johnson & Johnson

1. The Acquisition of Pfizer by Johnson & Johnson; will present the company to support growth for the Johnson & Johnson.
2. Johnson & Johnson has opportunity to increase market share by product development and product innovation globally.
3. Increase global presence by expanding globally through the joint ventures and acquisitions.
4. Expansion and innovation into diagnostics and medical devices will grants new markets to grow.
5. Financial economic recovery will boost the income of consumers which will ultimately increase the company revenues.
6. Assimilate current acquisitions of different companies. 

Threats

1. This industry may be on the restore, but its revival could be slowed down by heavy-handed regulation and more hurting in the housing market, amongst other things.
2. Johnson & Johnson has strong global competitors. These competitors provide alternative and substitute products at lower prices.
3. Johnson & Johnson is in the mature market with very low market growth rate.
4. Major pharmaceutical companies are facing strong competition for the generics markets from the local players.
5. Bio-technological expansion will potentially move the established pharmaceutical process out of the market in the future.
6. All the global players are facing strong regulations in the pharmaceutical industry by different respective countries.
7. Private label has increased the nonspecific drugs growth.